Drugs / rVV-740CTA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03110445 | Mar 2020 → Sep 2021 | breast carcinoma | University Hospital, Basel, Switzerland | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rVV-740CTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03110445 ↗ |
| Modality | Vaccine | “rVV-740CTA vaccine” NCT03110445 ↗ |